196 related articles for article (PubMed ID: 36310703)
1. Predictive value of a serum tumor biomarkers scoring system for clinical stage II/III rectal cancer with neoadjuvant chemoradiotherapy.
Zhao JY; Tang QQ; Luo YT; Wang SM; Zhu XR; Wang XY
World J Gastrointest Oncol; 2022 Oct; 14(10):2014-2024. PubMed ID: 36310703
[TBL] [Abstract][Full Text] [Related]
2. Combination of Changes in CEA and CA199 Concentration After Neoadjuvant Chemoradiotherapy Could Predict the Prognosis of Stage II/III Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision.
Zhao J; Zhao H; Jia T; Yang S; Wang X
Cancer Manag Res; 2022; 14():2933-2944. PubMed ID: 36200095
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of carcinoembryonic antigen and carbohydrate antigen 19-9 related to downstaging to stage 0-I after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Song J; Huang X; Chen Z; Chen M; Lin Q; Li A; Chen Y; Xu B
Cancer Manag Res; 2018; 10():3101-3108. PubMed ID: 30214303
[TBL] [Abstract][Full Text] [Related]
4. The combination of pre-neoadjuvant chemoradiotherapy inflammation biomarkers could be a prognostic marker for rectal cancer patients.
Zhang J; Zhang L; Gou Y; Diao P; Hu Y
Sci Rep; 2022 Mar; 12(1):4286. PubMed ID: 35277532
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of changes in the level of carbohydrate antigen 19-9 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Zheng Z; Wang X; Huang Y; Lu X; Chi P
Colorectal Dis; 2020 Dec; 22(12):2068-2077. PubMed ID: 32936987
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of indirect bilirubin before neoadjuvant chemoradiotherapy in evaluating prognosis of local advanced rectal cancer patients.
Li SF; Wei R; Yu GH; Jiang Z
World J Gastrointest Oncol; 2022 Nov; 14(11):2224-2237. PubMed ID: 36438711
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of CEA and CA19-9 in patients with local advanced rectal cancer receiving neoadjuvant chemoradiotherapy, radical surgery and postoperative chemotherapy.
Shan J; Gu B; Shi L; Wang X; Ye W; Zhou W; Sun X
Transl Cancer Res; 2021 Jan; 10(1):88-98. PubMed ID: 35116242
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy.
Lu S; Liu Z; Zhou X; Wang B; Li F; Ma Y; Wang W; Ma J; Wang Y; Wang H; Fu W
Cancer Manag Res; 2020; 12():8555-8568. PubMed ID: 32982448
[TBL] [Abstract][Full Text] [Related]
9. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.
Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH
Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of carcinoembryonic antigen combined with carbohydrate antigen 19-9 following neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Zheng Z; Wang X; Lu X; Huang Y; Chi P
Colorectal Dis; 2021 Sep; 23(9):2320-2330. PubMed ID: 33900006
[TBL] [Abstract][Full Text] [Related]
11. Clinical Impact of Preoperative Albumin-Globulin Ratio in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy.
Toiyama Y; Oki S; Okugawa Y; Ide S; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Inoue Y; Araki T; Kusunoki M
Oncology; 2018; 95(5):270-280. PubMed ID: 29996133
[TBL] [Abstract][Full Text] [Related]
12. Prognosis Can Be Predicted More Accurately Using Pre- and Postchemoradiotherapy Carcinoembryonic Antigen Levels Compared to Only Prechemoradiotherapy Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer Patients Who Received Neoadjuvant Chemoradiotherapy.
Sung S; Son SH; Kay CS; Lee YS
Medicine (Baltimore); 2016 Mar; 95(10):e2965. PubMed ID: 26962798
[TBL] [Abstract][Full Text] [Related]
13. Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer.
Wang R; Xu B; Sun M; Pang X; Wang X; Zhu J; Lian J; Lu H
Eur J Surg Oncol; 2023 Dec; 49(12):107138. PubMed ID: 37925830
[TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
15. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Impact of Carcinoembryonic Antigen Levels in Rectal Cancer Patients Who Had Received Neoadjuvant Chemoradiotherapy.
Joo JI; Lim SW; Oh BY
Ann Coloproctol; 2021 Jun; 37(3):179-185. PubMed ID: 33971705
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
18. High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients.
Lu S; Liu Z; Wang B; Li F; Meng Y; Wang J; Wang Y; Wang H; Zhou X; Fu W
Cancer Cell Int; 2021 Apr; 21(1):205. PubMed ID: 33849545
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the ratio of pretreatment carcinoembryonic antigen to tumor volume in rectal cancer.
Zeng Z; Ma D; Zhu P; Niu K; Fu S; Di X; Zhu J; Xie P
J Gastrointest Oncol; 2023 Dec; 14(6):2395-2408. PubMed ID: 38196531
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal Cancer.
Iseas S; Sendoya JM; Robbio J; Coraglio M; Kujaruk M; Mikolaitis V; Rizzolo M; Cabanne A; Ruiz G; Salanova R; Gualdrini U; Méndez G; Antelo M; Carballido M; Rotondaro C; Viglino J; Eleta M; Di Sibio A; Podhajcer OL; Roca E; Llera AS; Golubicki M; Abba MC
Front Oncol; 2021; 11():801880. PubMed ID: 35071006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]